New pertussis vaccination approaches: en route to protect newborns?

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

(2011) Daisy Higginson et al.   BMC PUBLIC HEALTH

The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization

(2011) D. M. Skowronski et al.   CLINICAL INFECTIOUS DISEASES

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis

(2011) Srinivas Garlapati et al.   VACCINE

Identification of a new protective antigen of Bordetella pertussis

(2011) Jimena Alvarez Hayes et al.   VACCINE

Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets

(2011) Monika. Polewicz et al.   VACCINE

Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate

(2011) Cristian J.A. Asensio et al.   VACCINE

Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations

(2011) Aleksandra Gracia et al.   VACCINE

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine

(2011) Jennie S. Lavine et al.   VACCINE

Is adolescent pertussis vaccination preferable to natural booster infections?

(2011) Hans O Hallander et al.   Expert Review of Clinical Pharmacology

Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model

(2010) H. Kavanagh et al.   CLINICAL AND EXPERIMENTAL ALLERGY

A Live, AttenuatedBordetella pertussisVaccine Provides Long-Term Protection against Virulent Challenge in a Murine Model

(2010) Ciaran M. Skerry et al.   Clinical and Vaccine Immunology

Dose Response of Attenuated Bordetella pertussis BPZE1-Induced Protection in Mice

(2010) N. Mielcarek et al.   Clinical and Vaccine Immunology

Vaccinate the Village

(2010) Alfred DeMaria Jr et al.   CLINICAL INFECTIOUS DISEASES

Implementation of Cocooning against Pertussis in a High-Risk Population

(2010) C. M. Healy et al.   CLINICAL INFECTIOUS DISEASES

Panel Backs Wider Pertussis Vaccination to Curb Outbreaks, Prevent Deaths

(2010) Bridget M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Booster Vaccination After Neonatal Priming with Acellular Pertussis Vaccine

(2010) Markus Knuf et al.   JOURNAL OF PEDIATRICS

Attenuated Bordetella pertussis Protects against Highly Pathogenic Influenza A Viruses by Dampening the Cytokine Storm

(2010) R. Li et al.   JOURNAL OF VIROLOGY

Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age

(2010) Nicholas Wood et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

T- and B-Cell-Mediated Protection Induced by Novel, Live Attenuated Pertussis Vaccine in Mice. Cross Protection against Parapertussis

(2010) Pascal Feunou Feunou et al.   PLoS One

Contact Network Structure Explains the Changing Epidemiology of Pertussis

(2010) P. Rohani et al.   SCIENCE

Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens

(2010) Doo-Hee Shim et al.   VACCINE

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination

(2010) Olivia J. White et al.   VACCINE

Imperfect vaccine-induced immunity and whooping cough transmission to infants

(2010) Jennie Lavine et al.   VACCINE

Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1

(2010) Pascal Feunou Feunou et al.   VACCINE

Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants

(2009) T. Q. Zorzeto et al.   Clinical and Vaccine Immunology

A Live Attenuated Bordetella pertussis Candidate Vaccine Does Not Cause Disseminating Infection in Gamma Interferon Receptor Knockout Mice

(2009) C. M. Skerry et al.   Clinical and Vaccine Immunology

Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen

(2009) Frits R. Mooi   INFECTION GENETICS AND EVOLUTION

Infant and Maternal Risk Factors for Pertussis-Related Infant Mortality in the United States, 1999 to 2004

(2009) Dana L. Haberling et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin

(2009) V. Bouchez et al.   VACCINE

Simian Varicella Virus Infection of Rhesus Macaques Recapitulates Essential Features of Varicella Zoster Virus Infection in Humans

(2009) Ilhem Messaoudi et al.   PLoS Pathogens

Poor Immune Responses to a Birth Dose of Diphtheria, Tetanus, and Acellular Pertussis Vaccine

(2008) Natasha B. Halasa et al.   JOURNAL OF PEDIATRICS

A common vaccination strategy to solve unsolved problems of tuberculosis and pertussis?

(2008) Camille Locht   MICROBES AND INFECTION

Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model

(2008) Nico Marr et al.   VACCINE

Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1

(2008) Pascal Feunou Feunou et al.   VACCINE

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

(2008) Joël Mossong et al.   PLOS MEDICINE

Neonatal Vaccination with an Acellular Pertussis Vaccine Accelerates the Acquisition of Pertussis Antibodies in Infants

(2007) Markus Knuf et al.   JOURNAL OF PEDIATRICS